{"2412.12475": {"publish_time": "2024-12-17", "title": "RareAgents: Autonomous Multi-disciplinary Team for Rare Disease Diagnosis and Treatment", "paper_summary": "Rare diseases, despite their low individual incidence, collectively impact\naround 300 million people worldwide due to the huge number of diseases. The\ncomplexity of symptoms and the shortage of specialized doctors with relevant\nexperience make diagnosing and treating rare diseases more challenging than\ncommon diseases. Recently, agents powered by large language models (LLMs) have\ndemonstrated notable improvements across various domains. In the medical field,\nsome agent methods have outperformed direct prompts in question-answering tasks\nfrom medical exams. However, current agent frameworks lack adaptation for\nreal-world clinical scenarios, especially those involving the intricate demands\nof rare diseases. To address these challenges, we present RareAgents, the first\nmulti-disciplinary team of LLM-based agents tailored to the complex clinical\ncontext of rare diseases. RareAgents integrates advanced planning capabilities,\nmemory mechanisms, and medical tools utilization, leveraging Llama-3.1-8B/70B\nas the base model. Experimental results show that RareAgents surpasses\nstate-of-the-art domain-specific models, GPT-4o, and existing agent frameworks\nin both differential diagnosis and medication recommendation for rare diseases.\nFurthermore, we contribute a novel dataset, MIMIC-IV-Ext-Rare, derived from\nMIMIC-IV, to support further advancements in this field.", "paper_summary_zh": "\u5118\u7ba1\u7f55\u898b\u75be\u75c5\u7684\u500b\u5225\u767c\u751f\u7387\u5f88\u4f4e\uff0c\u4f46\u7531\u65bc\u75be\u75c5\u6578\u91cf\u9f90\u5927\uff0c\u5728\u5168\u7403\u5f71\u97ff\u4e86\u7d04 3 \u5104\u4eba\u3002\u75c7\u72c0\u7684\u8907\u96dc\u6027\u548c\u76f8\u95dc\u7d93\u9a57\u7684\u5c08\u79d1\u91ab\u751f\u77ed\u7f3a\uff0c\u4f7f\u5f97\u8a3a\u65b7\u548c\u6cbb\u7642\u7f55\u898b\u75be\u75c5\u6bd4\u5e38\u898b\u75be\u75c5\u66f4\u5177\u6311\u6230\u6027\u3002\u6700\u8fd1\uff0c\u7531\u5927\u578b\u8a9e\u8a00\u6a21\u578b (LLM) \u9a45\u52d5\u7684\u4ee3\u7406\u5df2\u5728\u5404\u500b\u9818\u57df\u5c55\u793a\u51fa\u986f\u8457\u7684\u6539\u9032\u3002\u5728\u91ab\u5b78\u9818\u57df\uff0c\u4e00\u4e9b\u4ee3\u7406\u65b9\u6cd5\u5728\u91ab\u5b78\u8003\u8a66\u7684\u554f\u7b54\u4efb\u52d9\u4e2d\u512a\u65bc\u76f4\u63a5\u63d0\u793a\u3002\u7136\u800c\uff0c\u7576\u524d\u7684\u4ee3\u7406\u67b6\u69cb\u7f3a\u4e4f\u9069\u61c9\u73fe\u5be6\u4e16\u754c\u7684\u81e8\u5e8a\u5834\u666f\uff0c\u7279\u5225\u662f\u90a3\u4e9b\u6d89\u53ca\u7f55\u898b\u75be\u75c5\u8907\u96dc\u9700\u6c42\u7684\u5834\u666f\u3002\u70ba\u4e86\u61c9\u5c0d\u9019\u4e9b\u6311\u6230\uff0c\u6211\u5011\u63d0\u51fa\u4e86 RareAgents\uff0c\u9019\u662f\u7b2c\u4e00\u500b\u91dd\u5c0d\u7f55\u898b\u75be\u75c5\u8907\u96dc\u81e8\u5e8a\u80cc\u666f\u91cf\u8eab\u6253\u9020\u7684 LLM \u70ba\u57fa\u790e\u7684\u591a\u5b78\u79d1\u4ee3\u7406\u5718\u968a\u3002RareAgents \u6574\u5408\u4e86\u5148\u9032\u7684\u898f\u5283\u80fd\u529b\u3001\u8a18\u61b6\u6a5f\u5236\u548c\u91ab\u7642\u5de5\u5177\u5229\u7528\uff0c\u5229\u7528 Llama-3.1-8B/70B \u4f5c\u70ba\u57fa\u790e\u6a21\u578b\u3002\u5be6\u9a57\u7d50\u679c\u8868\u660e\uff0cRareAgents \u5728\u7f55\u898b\u75be\u75c5\u7684\u9451\u5225\u8a3a\u65b7\u548c\u85e5\u7269\u63a8\u85a6\u65b9\u9762\u90fd\u8d85\u8d8a\u4e86\u6700\u5148\u9032\u7684\u7279\u5b9a\u9818\u57df\u6a21\u578b GPT-4o \u548c\u73fe\u6709\u7684\u4ee3\u7406\u67b6\u69cb\u3002\u6b64\u5916\uff0c\u6211\u5011\u8ca2\u737b\u4e86\u4e00\u500b\u65b0\u7684\u6578\u64da\u96c6 MIMIC-IV-Ext-Rare\uff0c\u5b83\u4f86\u81ea MIMIC-IV\uff0c\u4ee5\u652f\u6301\u8a72\u9818\u57df\u7684\u9032\u4e00\u6b65\u767c\u5c55\u3002", "author": "Xuanzhong Chen et.al.", "authors": "Xuanzhong Chen, Ye Jin, Xiaohao Mao, Lun Wang, Shuyang Zhang, Ting Chen", "id": "2412.12475v1", "paper_url": "http://arxiv.org/abs/2412.12475v1", "repo": "null"}}